Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program

Sponsor

Washington University School of Medicine (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05602896

Collaborator

BJC HealthCare (Other), Viven Health (Other)

100

Enrollment

Location

Arm

16.1

Anticipated Duration (Months)

6.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study will advance the knowledge in the field by determining the effectiveness of discharge education regarding prevention of a new infection which is the highest cause of readmission for sepsis patient. In evaluating the impact care teams will develop a clearer link between specific home-based education interventions and infection prevention. This study is an exploratory study designed to identify whether patient education through an innovative teaching method can have an impact on readmissions. This study may the first of several based on findings from this initial, exploratory study.

Condition or Disease	Intervention/Treatment	Phase
Sepsis	Other: Sepsis education	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

100 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Prevention

Official Title:

Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program

Anticipated Study Start Date :

Jun 30, 2023

Anticipated Primary Completion Date :

Oct 31, 2024

Anticipated Study Completion Date :

Oct 31, 2024

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Sepsis Education The patient will receive a daily notification via their mobile phone and conduct the daily activity for 30 days. The program is interactive and aimed at measures that prevent exposure to infection sources in the environment, as well as recognition of early signs of infection and possible sepsis. Each session takes approximately 2 minutes or less. Each scenario or session has the user identify where germs may be present and then asks the user to perform a simple action to remove the germs (e.g. with an antiseptic wipe). The range of activities include cleaning of surfaces, proper mask use, and hand sanitizing. This includes areas of their home such as the kitchen, bathroom, living room/family room. The program also addresses common community areas such as public transit, grocery stores, and restaurants	Other: Sepsis education The education program has been reviewed and approved by BJH Center for Practice Excellence

Arm

Intervention/Treatment

Experimental: Sepsis Education

The patient will receive a daily notification via their mobile phone and conduct the daily activity for 30 days. The program is interactive and aimed at measures that prevent exposure to infection sources in the environment, as well as recognition of early signs of infection and possible sepsis. Each session takes approximately 2 minutes or less. Each scenario or session has the user identify where germs may be present and then asks the user to perform a simple action to remove the germs (e.g. with an antiseptic wipe). The range of activities include cleaning of surfaces, proper mask use, and hand sanitizing. This includes areas of their home such as the kitchen, bathroom, living room/family room. The program also addresses common community areas such as public transit, grocery stores, and restaurants

Other: Sepsis education

The education program has been reviewed and approved by BJH Center for Practice Excellence

Outcome Measures

Primary Outcome Measures

Readmission rates [4 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 85 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Oncology patients discharged to home following a diagnosis of sepsis, severe sepsis or septic shock
Patient must have a mobile phone/device
English speakers
Age range 18 - 85 years

Exclusion Criteria:

Less than 18 years of age and older than 85 years of age
No mobile phone/device
Non-English speaking
No diagnosis of sepsis, severe sepsis, or septic shock
Non-Oncology patient

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Barnes-Jewish Hospital	Saint Louis	Missouri	United States	63110

Sponsors and Collaborators

Washington University School of Medicine
BJC HealthCare
Viven Health

Investigators

Principal Investigator: Nancy Bickel, MSN, APRN, ANCP-BC, ACNS-BC, BJC HealthCare

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Publications

None provided.

Responsible Party:

Washington University School of Medicine

ClinicalTrials.gov Identifier:

NCT05602896

Other Study ID Numbers:

202207066

First Posted:

Nov 2, 2022

Last Update Posted:

Jan 25, 2023

Last Verified:

Jan 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Washington University School of Medicine

sepsis

education

cancer

Additional relevant MeSH terms:

Sepsis

Toxemia

Study Results

No Results Posted as of Jan 25, 2023